A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

Clinical trial NCT07476378 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07476378
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, Follicular Lymphoma, Mantle-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Lymphoma, B-Cell, Marginal Zone Transformed Follicular Lymphoma (TFL)

Start date: 2026-03-01
Primary completion: 2028-01-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.